Kyme Pierre
SEC insider (Form 3/4/5 filer). CIK 0002028892. Chief Business Officer at Armata Pharmaceuticals, Inc. (ARMP). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 14, 2026. Located in LOS ANGELES, CA.
Companies Kyme Pierre has filed insider reports for
- Armata Pharmaceuticals, Inc. (ARMP): Officer, Chief Business Officer
Kyme Pierre
CIK: 0002028892
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Armata Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 14, 2026ARMP
Armata Pharmaceuticals, Inc.
Tax PaymentDirect1K shares at avg. $10.54$11K - Mar 9, 2026ARMP
Armata Pharmaceuticals, Inc.
AwardDirectStock Options (Right to Buy)
183.1K shares- - Mar 14, 2025ARMP
Armata Pharmaceuticals, Inc.
Tax PaymentDirect1K shares at avg. $1.95$2K - Feb 5, 2025ARMP
Armata Pharmaceuticals, Inc.
AwardDirectStock Options (Right to Buy)
100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 14, 2026 | ARMP Armata Pharmaceuticals, Inc. | Tax Payment | 1,030 | $10.54 | $10,856 | Direct |
| Mar 9, 2026 | ARMP Armata Pharmaceuticals, Inc. | Award Stock Options (Right to Buy) | 183,142 | - | - | Direct |
| Mar 14, 2025 | ARMP Armata Pharmaceuticals, Inc. | Tax Payment | 1,027 | $1.95 | $2,003 | Direct |
| Feb 5, 2025 | ARMP Armata Pharmaceuticals, Inc. | Award Stock Options (Right to Buy) | 100,000 | - | - | Direct |
1-4 of 4 transactions